Th9 cells have been shown to enhanced the cytotoxicity of peripheral non-specific CD8+ T cells in a direct cell-to-cell contact manner in acute coronary syndrome (19) and breast cancer (20). The gene discussed is CD8A; the disease is breast cancer.